The pathological role of IL-18Rα in renal ischemia/reperfusion injury

Laboratory Investigation

Volumn 95, Issue 1, 2015, Pages 78-91

  Yano, Tomohiro ^a   Nozaki, Yuji ^a   Kinoshita, Koji ^a   Hino, Shoichi ^a   Hirooka, Yasuaki ^a   Niki, Kaoru ^a   Shimazu, Hideki ^a   Kishimoto, Kazuya ^a   Funauch, Masanori ^a   Matsumura, Itaru ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; FAS ANTIGEN; FAS LIGAND; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 1BETA; KIDNEY INJURY MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN; RECOMBINANT INTERLEUKIN 18; UREA; AUTACOID; INTERLEUKIN 18 RECEPTOR; PRIMER DNA;

ACUTE KIDNEY FAILURE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; LEUKOCYTE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REPERFUSION INJURY; SPLEEN CELL; UREA NITROGEN BLOOD LEVEL; WILD TYPE; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; GENETICS; KNOCKOUT MOUSE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VASCULARIZATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; DNA PRIMERS; INFLAMMATION MEDIATORS; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-18; REPERFUSION INJURY;

EID: 84920094512     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.120     Document Type: Article

References (45)

1. Striz I, Krasna E, Honsova E, et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett 2005;99:30-35.
2. Sareneva T, Julkunen I, Matikainen S. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 2000;165:1933-1938.
3. Torigoe K, Ushio S, Okura T, et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 1997;272: 25737-25742.
4. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
5. Timo S, Ilkka J, Sampsa M. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 2000;165:1933-1938.
6. Laura F, Patrizia P, Barbara V, et al. IFN-α and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-g production in mouse macrophages: novel pathways in the regulation ofthe inflammatory response of macrophages. J Leukoc Biol 2000;68:707-714.
7. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005;16:3046-3052.
8. Bani-Hani AH, Leslie JA, Asanuma H, et al. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int 2009;76:500-511.
9. Nogae S, Miyazaki M, Kobayashi N, et al. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J Am Soc Nephrol 1998;9:620-631.
10. Ortiz A, Lorz C, Egido J. The Fas ligand/Fas system in renal injury. Nephrol Dial Transplant 1999;14:1831-1834.
11. Brunner T, Mogil RJ, LaFace D, et al. Cell-autonomous Fas (CD95)/Fasligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444.
12. Dupont PJ, Warrens AN. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology 2007; 120:133-139.
13. Cruise MW, Melief HM, Lukens J, et al. Increased Fas ligand expression of CD4 - T cells by HCV core induces T celldependent hepatic inflammation. J Leukoc Biol 2005;78:412-425.
14. Park DR, Thomsen AR, Frevert CW, et al. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 2003;170:6209-6216.
15. Hamad AR, Schneck JP. Antigen-induced T cell death is regulated by CD4 expression. Int Rev Immunol 2001;20:535-546.
16. Zhang H, Hile KL, Asanuma H, et al. IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism. Am J Physiol Renal Physiol 2011;301:171-178.
17. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23:460-464.
18. Phoon RK, Kitching AR, Odobasic D, et al. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2008;19:477-485.
19. Nozaki Y, Nikolic-Paterson DJ, Snelgrove SL, et al. Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int 2011;81: 844-855.
20. Nozaki Y, Tamaki C, Yamagata T, et al. All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis. Rheumatol Int 2006;26:810-817.
21. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007;117:2847-2859.
22. Meldrum KK, Meldrum DR, Hile KL, et al. A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res 2001;99:288-293.
23. Liu M, Chien CC, Burne-Taney M, et al. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 2006;17:765-774.
24. Fiorina P, Ansari MJ, Jurewicz M, et al. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 2006;17: 716-723.
25. Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ. Poly (ADPribose) polymerase-mediated cell injury in acute renal failure. Pharmacol Res 2005;52:44-59.
26. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004;66:480-485.
27. Rabb H, O'Meara YM, Maderna P, et al. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997;51: 1463-1468.
28. Wyburn K, Wu H, Yin J, et al. Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrol Dial Transplant 2005;20:699-706.
29. Nozaki Y, Kinoshita K, Yano T, et al. Signaling through the interleukin- 18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury. Kidney Int 2012;82:892-902.
30. Kinoshita K, Yamagata T, Nozaki Y, et al. Blockade of IL-18 receptor signaling delays the onset of autoimmune disease in MRL-Faslpr mice. J Immunol 2004;173:5312-5318.
31. Ghose P, Ali AQ, Fang R, et al. The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria. J Immunol 2011;187:1333-1346.
32. Dinarello CA, Novick D, Puren AJ, et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998;63:658-664.
33. Finotto S, Siebler J, Hausding M, et al. Severe hepaticinjury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 2004;53:392-400.
34. Mariño E, Cardier JE. Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95). Cytokine 2003;22:142-148.
35. Ohtsuki T, Micallef MJ, Kohno K, et al. Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 1997;17:3253-3258.
36. Furuichi K, Kokubo S, Hara A, et al. Fas ligand has a greater impact than TNF-α on apoptosis and inflammation in ischemic acute kidney injury. Nephron Extra 2012;2:27-38.
37. Murphy KM, Streips UN, Lock RB. Bax membrane insertion during Fas (CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene 1999;18:5991-5999.
38. Takagi H, Kanai T, Okazawa A, et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand J Gastroenterol 2003;38:837-844.
39. Lewis EC, Dinarello CA. Responses of IL-18- and IL-18 receptordeficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc Natl Acad Sci USA 2006;103:16852-16857.
40. Fehniger TA, Shah MH, Turner MJ, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999;162:4511-4520.
41. Nold-Petry CA, Nold MF, Nielsen JW, et al. Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling. J Biol Chem 2009;284:25900-25911.
42. Kanakaraj P, Nqo K, Wu Y, et al. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptorassociated kinase (IRAK)-deficient mice. J Exp Med 1999;189: 1129-1138.
43. Fantuzzi L, Puddu P, Varano B, et al. IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages. J Leukoc Biol 2000;68:707-714.
44. Kitaura H, Nagata N, Fujimura Y, et al. Effect of IL-12 on TNF-α-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction. J Immunol 2002;169:4732-4738.
45. Fan X, Oertli B, Wüthrich RP. Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas (lpr) mice with renal injury. Kidney Int 1997;51:79-86.